-+ 0.00%
-+ 0.00%
-+ 0.00%

Nuvectis Pharma Q3 EPS $(1.02) Misses $(0.24) Estimate

Benzinga·11/04/2026 12:13:02
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.24) by 325 percent. This is a 131.82 percent decrease over losses of $(0.44) per share from the same period last year.